ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $206,489 | +391.6% | 6,748 | +461.9% | 0.00% | – |
| Q2 2022 | $42,000 | -6.7% | 1,201 | +22.4% | 0.00% | – |
| Q1 2022 | $45,000 | -25.0% | 981 | +7.9% | 0.00% | – |
| Q4 2021 | $60,000 | +9.1% | 909 | +4.0% | 0.00% | – |
| Q3 2021 | $55,000 | -21.4% | 874 | +3.6% | 0.00% | -100.0% |
| Q2 2021 | $70,000 | -76.8% | 844 | -81.5% | 0.00% | -66.7% |
| Q1 2021 | $302,000 | -6.2% | 4,557 | +8.5% | 0.00% | -25.0% |
| Q4 2020 | $322,000 | +94.0% | 4,200 | +13.5% | 0.00% | +33.3% |
| Q3 2020 | $166,000 | +7.1% | 3,700 | +5.7% | 0.00% | 0.0% |
| Q2 2020 | $155,000 | +66.7% | 3,500 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $93,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |